AAV8-MYO7A gene therapy (Fondazione Telethon)

N/A

Report date: 2025/03/14 16:43:46

Base Information

Drug NameAAV8-MYO7A gene therapy (Fondazione Telethon)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionMyosin VIIA Gene transference
TargetsMyosin VIIA
Therapy Area/IndicationsUsher Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFondazione Telethon
China Registration ClassN/A

Develop Information

Active CompaniesFondazione Telethon
Inactive CompaniesN/A
Active IndicationsUsher Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A